脓毒症临床实践指南质量评估及推荐意见差异
该研究检索2018年1月1日至2025年3月1日电子数据库、指南库与专业学会,纳入11部成人脓毒症管理临床实践指南,采用AGREE II与AGREE-REX评估方法学质量与推荐质量,并提取比较关键推荐。AGREE II各域中位分:范围与目的88.89%、利益相关方参与83.33%、制定严谨性58.33%、表达清晰性94.40%、适用性45.83%、编辑独立性66.67%;AGREE-REX临床适用性70.83%、可实施性58.33%、价值观与偏好30.21%。共提取552条关键推荐;采用GRADE的指南中低质量(C级97条,40.93%)与极低质量证据(D级66条,27.85%)比例高于高质量(A级15条,6.33%)与中等质量(B级59条,24.89%),弱推荐(168条,70.89%)多于强推荐(69条,29.11%)。脓毒症诊断推荐总体一致,但血流动力学管理与抗生素使用存在证据缺口并导致争议性推荐。
要点
- 共纳入11部成人脓毒症指南,AGREE II适用性域中位分仅45.83%,为各域最低。
- AGREE-REX价值观与偏好域中位分仅30.21%,可实施性58.33%。
- 采用GRADE的指南中,弱推荐168条(70.89%)明显多于强推荐69条(29.11%)。
- 低质量(C级97条,40.93%)与极低质量证据(D级66条,27.85%)比例高于高质量(A级15条,6.33%)与中等质量(B级59条,24.89%)。
- 脓毒症诊断推荐总体一致,血流动力学管理与抗生素使用推荐存在争议。
适用人群与场景
- 成人脓毒症管理相关临床实践指南的制定与评估场景,非直接患者人群干预研究。
研究设计与关键结果
- 研究类型为指南质量评估,纳入11部成人脓毒症管理临床实践指南,检索时间2018年1月1日至2025年3月1日。
- AGREE II各域中位(IQR)分:范围与目的88.89%(77.78–94.44%)、利益相关方参与83.33%(50.00–88.89%)、制定严谨性58.33%(50.00–83.33%)、表达清晰性94.40%(88.89–94.44%)、适用性45.83%(33.33–66.67%)、编辑独立性66.67%(58.33–91.67%)。
- AGREE-REX评估:临床适用性70.83%(63.89–83.33%)、可实施性58.33%(47.92–64.58%)、价值观与偏好30.21%(25.00–39.58%)。
- 共提取552条关键推荐;采用GRADE系统的指南中,低质量证据C级97条(40.93%)、极低质量证据D级66条(27.85%)、高质量证据A级15条(6.33%)、中等质量证据B级59条(24.89%)。
- 弱推荐168条(70.89%)多于强推荐69条(29.11%)。
- 脓毒症诊断推荐总体一致,血流动力学管理与抗生素使用因证据缺口导致争议性推荐。
证据类型、等级与局限
- 证据类型:指南质量评估研究(系统检索并评估临床实践指南)。
- 采用AGREE II与AGREE-REX工具评估,未报告证据等级或推荐强度分级体系。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该评估提示脓毒症指南在适用性与价值观与偏好方面质量有待提高,作者建议未来指南制定者严格遵循标准化方法并加强指南的传播与实施。
- 脓毒症诊断推荐在各类指南间总体一致,而血流动力学管理与抗生素使用推荐存在争议,临床决策时需注意指南间的差异。
指南或共识出处
- 原文为对11部成人脓毒症管理临床实践指南的质量评估,未列出所评估指南的具体名称。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To provide a clinical reference, we assessed the quality of clinical practice guidelines (CPGs) for sepsis management in adults and compared their key recommendations. METHODS: Relevant CPGs for adult sepsis management were identified through searches of electronic databases, guideline repositories, and professional societies from January 1, 2018, to March 1, 2025. The Appraisal of Guidelines Research and Evaluation (AGREE) II instrument and the Appraisal of Guidelines for Research and Evaluation-Recommendation Excellence (AGREE-REX) were used to evaluate the methodological quality of CPGs and the quality of recommendations. Key recommendations were comprehensively extracted and compared. RESULTS: A total of 11 CPGs were included. The median (interquartile range [IQR]) scores for AGREE II domain were: scope and purpose, 88.89% (77.78–94.44%); stakeholder involvement, 83.33% (50.00–88.89%); rigor of development, 58.33% (50.00–83.33%); clarity of presentation, 94.40% (88.89–94.44%); applicability, 45.83% (33.33–66.67%); and editorial independence, 66.67% (58.33–91.67%). The AGREE-REX assessment indicated clinical applicability at 70.83% (63.89–83.33%), implementability at 58.33% (47.92–64.58%), and values and preferences at 30.21% (25.00–39.58%). In total, 552 key recommendations were extracted. Among guidelines utilizing the GRADE system, the proportion of evidence categorized as low (Grade C; n = 97, 40.93%) and very low quality (Grade D; n = 66, 27.85%) was substantially higher than that of high (Grade A; n = 15, 6.33%) and moderate-quality (Grade B; n = 59, 24.89%) evidence. Furthermore, weak recommendations (n = 168, 70.89%) were markedly more prevalent than strong recommendations (n = 69, 29.11%). Although guidelines for sepsis diagnosis were generally consistent, evidence gaps in hemodynamic management and antibiotic use led to controversial recommendations. CONCLUSION: Treatment strategies for sepsis vary across guidelines and remain inconsistent. The quality of CPGs for sepsis management requires improvement, particularly in applicability and values and preferences. Future CPG developers should adhere strictly to standardized methodologies and focus on enhancing the dissemination and implementation of guidelines. In this study, we lay the foundation for future guideline development, aiming to synthesize evidence-based insights for clinical decision-making.
参考来源
- Li HY, Jiang SL, Wang J, et al. Quality assessment of clinical practice guidelines for sepsis and variations in recommendations. BMC Infect Dis. 2025. PMID: 41436952. doi:10.1186/s12879-025-12434-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。